scholarly journals Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma

Head & Neck ◽  
2015 ◽  
Vol 38 (S1) ◽  
pp. E566-E570 ◽  
Author(s):  
Matthew G. Fury ◽  
Han Xiao ◽  
Eric J. Sherman ◽  
Shrujal Baxi ◽  
Stephanie Smith-Marrone ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document